During the past decade, Mitchell Folbe MD PC conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 17 clinical trials were completed, i.e. on average, 58.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 17 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mitchell Folbe MD PC" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Bristol-Myers Squibb" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mitchell Folbe MD PC" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Mitchell Folbe MD PC" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Stage II Breast Cancer" (4 trials) and "Stage IIA Breast Cancer" (3 trials). Many other conditions were trialed in "Mitchell Folbe MD PC" in a lesser frequency.

Most popular intervention types in "Mitchell Folbe MD PC" are "Drug" (32 trials), "Other" (31 trials), "Biological" (11 trials), "Procedure" (10 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (10 trials), "Carboplatin" (5 trials), "Computed Tomography" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Mitchell Folbe MD PC" are 37 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Mitchell Folbe MD PC". undefined are not yet recruiting, 3 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Mitchell Folbe MD PC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mitchell Folbe MD PC, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".